Free PSA in the detection of prostatic carcinoma

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3015-3018

  Wechsel, P Hans W ^a   Petri, Eckhardt ^a   Bichler, K Horst ^a   Schreiber, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

BPH; Free psa; Prostate carcinoma; PSA

Indexed keywords

GONADORELIN DERIVATIVE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE DISEASE; PROSTATE HYPERTROPHY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 1842291520     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Gustafsson O, Norming U, Almgard L-E, Fredriksso A, Gustavsson G, Harvig B, Nyman CR: Diagnostic Methods In The Detection Of Prostate Cancer: A Study Of A Randomly Selected Population Of 2,400 Men. J Urol 148: 1827-1831, 1992.
2. Vessella RL, Lange PH: Issues In The Assessment Of PSA Immunoassays. Urol Clin North Am 20: 607-619, 1993.
3. Strohmaier WL, Zumbrägel A, Bichler K-H: Heutiger Stand der prostata-spezifischen sauren Phosphatasc (PAP) als Tumormarker für das Prostata-karziniom (PC). 36. Tagung der Südwestdeutschen GesellschaR für Urologie, 25.-27.05.95, Offenbach/Frankfurth a. M.
4. Wechsel HW, Heidenreich A, Bichler K-H: Ist eine Bestimmung der Ske-lettphosphatase (ASP) als Tumormarker in der Nachsorge beim fortgeschrit-tenen Prostatakarzinom (D2) sinnvoll? Urol. B 34: 187-188, 1994.
5. Bichler K-H, Petri E, Hub A, Kleinknecht A: Heidenreich: Investigations on bone metabolism of urologie tumors forming metastasis. Urol Int (in press 1995).
6. Tarle M, Frkovic-Gracio S, Kraljic I, Kovascic K: A More Objective Staging Of Advanced Prostate Cancer - Routine Recognition Of Malignant Endocrine Structures: The Assessment Of Serum TPS, PSA and NSE Values The Prostate 24: 143-148, 1994.
7. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM: Influence Of Patient Age On The Serum PSA Concentration: An Important Clinical Observation. Urol Clin North Am 20: 671-680, 1993.
8. Mettlin C, Littrup PJ, Kane RA, Murphy GP, Lee F, Chesley A, Badalament R, Mostofi FK: Relative Sensitivity and Spezifity of Serum Prostate Specific Antigen (PSA) Level Compared with Age-Referenced PSA, PSA-Density, and PSA Change. Cancer 74: 1615-1620, 1994.
9. Stamey A, Chen Z, Prestigiacomo A: Serum Prostate Spezific Antigen Binding alpha-1 Antichymotripsin: Influence of Cancer Volume. Location, and Therapeutic Selection Of Resistant Clones J Urol 152: 1510-1514, 1994.
10. Lilja H: Structure, function and regulation of the enzyme activity of prostate-spezific antigen World J Urol 11: 188-191, 1993.
11. Lilja H: Significance of Different Molecular Forms of Serum PSA. Urol Clin North Am 20: 681-686, 1993.
12. Petros JA, Andriole GL: Serum PSA ARer Antiandrogen Therapy Urol Clin North Am 20: 749-756, 1993.
13. Christensson A, Bjork T, Nielsson O, Dahlen U, Matikainen T, Cockett ATK, Abrahamsson P-A, Lilja H: Serum Prostate Specific Antigen Complexed To alpha-1 Antichymotrypsin As An Indicator Of Prostate Cancer J Urol 150: 100-105, 1993.